First Eagle Investment Management LLC bought a new stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 57,019 shares of the company's stock, valued at approximately $1,466,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. acquired a new position in Perrigo during the third quarter valued at $3,717,000. Foundry Partners LLC purchased a new position in Perrigo in the third quarter valued at $7,111,000. Barclays PLC increased its holdings in Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company's stock valued at $3,160,000 after buying an additional 37,268 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Perrigo by 65.1% in the third quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock valued at $14,190,000 after buying an additional 213,221 shares in the last quarter. Finally, Citigroup Inc. increased its holdings in Perrigo by 94.1% in the third quarter. Citigroup Inc. now owns 151,520 shares of the company's stock valued at $3,974,000 after buying an additional 73,457 shares in the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.
Perrigo Price Performance
Shares of PRGO stock traded up $0.60 on Thursday, reaching $28.48. 2,025,663 shares of the company were exchanged, compared to its average volume of 1,435,987. The company has a market cap of $3.89 billion, a price-to-earnings ratio of -24.34 and a beta of 0.48. The business has a 50-day moving average price of $25.59 and a 200 day moving average price of $26.17. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46.
Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping analysts' consensus estimates of $0.92 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Equities research analysts forecast that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.
Perrigo Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, March 7th. This is a positive change from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a yield of 4.07%. Perrigo's payout ratio is presently -92.80%.
Insider Buying and Selling
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.70% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
PRGO has been the subject of a number of recent analyst reports. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Piper Sandler cut shares of Perrigo from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $34.00 to $27.00 in a report on Monday, January 6th. Finally, StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $33.00.
Read Our Latest Report on PRGO
About Perrigo
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.